Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TRPC5 ELISA Kit (AC2597)
Cat.#: ASET-1186
Specifications
Description Human TRPC5 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human TRPC5 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.032 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1521 Porcine eNOS ELISA Kit (AC2932) Quantitative inquiry ASET-1064 Mouse TSH beta ELISA Kit (AC2475) Quantitative inquiry ASET-1372 Human Bim ELISA Kit (AC2783) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-1138 Human LUZP1 ELISA Kit (AC2549) Quantitative inquiry ASET-1693 Human UCP3 ELISA Kit (AC3104) Quantitative inquiry ASET-1319 Guinea Pig BDNF ELISA Kit (AC2730) Quantitative inquiry ASET-2350 Human P2Y12 ELISA Kit (AC3761) Quantitative inquiry ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket